Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group

BACKGROUND AND OBJECTIVE: Several different factors play role in developing gastric and colon cancers including infectious agents. Since there is no study about association of human T-lymphotropic virus 1 (HTLV-1) with cancers of digestive organ yet, so this study was performed to investigate the fr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	SE Tahaei, SR Fatemi, SR Mohebbi, P Mohammadi, F Nemati Malek, P Azimzadeh, MR Zali
Formato:	article
Lenguaje:	EN FA
Publicado:	Babol University of Medical Sciences 2012
Materias:	htlv-1 stomach neoplasms large intestine neoplasms seroepidemiologic study Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a432e27bc75f4561969b70ffe4d47a22
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a432e27bc75f4561969b70ffe4d47a22
record_format	dspace
spelling	oai:doaj.org-article:a432e27bc75f4561969b70ffe4d47a222021-11-10T08:53:33ZStudy of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group1561-41072251-7170https://doaj.org/article/a432e27bc75f4561969b70ffe4d47a222012-11-01T00:00:00Zhttp://jbums.org/article-1-4235-en.htmlhttps://doaj.org/toc/1561-4107https://doaj.org/toc/2251-7170BACKGROUND AND OBJECTIVE: Several different factors play role in developing gastric and colon cancers including infectious agents. Since there is no study about association of human T-lymphotropic virus 1 (HTLV-1) with cancers of digestive organ yet, so this study was performed to investigate the frequency of this infection in patients infected with gastric and colorectal cancers.METHODS: This project was performed as a case-control study between years 2009 to 2012. Two hundred and sixty five patients were cases of gastric and colorectal cancer confirmed by pathology and 244 healthy subjects were those who underwent endoscopy and colonoscopy and shown no sign of abnormality. We used third generation ELISA on sera of these people to assess their anti-HTLV-1 antibody status. FINDINGS: Two hundred and one GC patients, 64 CRC patients and 244 control subjects were enrolled in this study. Mean age of GC patients in the time of diagnosis was 59.24±12.50 years, CRC patients 58.98±13.39 and control subjects 57.83±11.25 years. One GC patient was positive for HTLV-1 antibody, no CRC patient was positive, while 4 control subjects had antibody against HTLV-1. There was no significant relationship between antibody positivity and gastric cancer or colorectal cancer.CONCLUSION: On the basis of current study, even though the rate of infection with this virus in GC patients was lower than control subjects.SE Tahaei,SR Fatemi,SR MohebbiP MohammadiF Nemati Malek,P AzimzadehMR ZaliBabol University of Medical Sciencesarticlehtlv-1stomach neoplasmslarge intestine neoplasmsseroepidemiologic studyMedicineRMedicine (General)R5-920ENFAMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, Vol 14, Iss 6, Pp 91-96 (2012)
institution	DOAJ
collection	DOAJ
language	EN FA
topic	htlv-1 stomach neoplasms large intestine neoplasms seroepidemiologic study Medicine R Medicine (General) R5-920
spellingShingle	htlv-1 stomach neoplasms large intestine neoplasms seroepidemiologic study Medicine R Medicine (General) R5-920 SE Tahaei, SR Fatemi, SR Mohebbi P Mohammadi F Nemati Malek, P Azimzadeh MR Zali Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
description	BACKGROUND AND OBJECTIVE: Several different factors play role in developing gastric and colon cancers including infectious agents. Since there is no study about association of human T-lymphotropic virus 1 (HTLV-1) with cancers of digestive organ yet, so this study was performed to investigate the frequency of this infection in patients infected with gastric and colorectal cancers.METHODS: This project was performed as a case-control study between years 2009 to 2012. Two hundred and sixty five patients were cases of gastric and colorectal cancer confirmed by pathology and 244 healthy subjects were those who underwent endoscopy and colonoscopy and shown no sign of abnormality. We used third generation ELISA on sera of these people to assess their anti-HTLV-1 antibody status. FINDINGS: Two hundred and one GC patients, 64 CRC patients and 244 control subjects were enrolled in this study. Mean age of GC patients in the time of diagnosis was 59.24±12.50 years, CRC patients 58.98±13.39 and control subjects 57.83±11.25 years. One GC patient was positive for HTLV-1 antibody, no CRC patient was positive, while 4 control subjects had antibody against HTLV-1. There was no significant relationship between antibody positivity and gastric cancer or colorectal cancer.CONCLUSION: On the basis of current study, even though the rate of infection with this virus in GC patients was lower than control subjects.
format	article
author	SE Tahaei, SR Fatemi, SR Mohebbi P Mohammadi F Nemati Malek, P Azimzadeh MR Zali
author_facet	SE Tahaei, SR Fatemi, SR Mohebbi P Mohammadi F Nemati Malek, P Azimzadeh MR Zali
author_sort	SE Tahaei,
title	Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
title_short	Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
title_full	Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
title_fullStr	Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
title_full_unstemmed	Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group
title_sort	study of anti-htlv-1 antibody frequency in gastric cancer and colorectal cancer patients in compare to control group
publisher	Babol University of Medical Sciences
publishDate	2012
url	https://doaj.org/article/a432e27bc75f4561969b70ffe4d47a22
work_keys_str_mv	AT setahaei studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT srfatemi studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT srmohebbi studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT pmohammadi studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT fnematimalek studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT pazimzadeh studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup AT mrzali studyofantihtlv1antibodyfrequencyingastriccancerandcolorectalcancerpatientsincomparetocontrolgroup
_version_	1718440404910604288

Study of Anti-HTLV-1 Antibody Frequency in Gastric Cancer and Colorectal Cancer Patients in Compare to Control Group

Ejemplares similares